Panel Seeks FDI Curbs in Hospitals to Aid Patients

The Cliff News | 5 October 2026

A crucial parliamentary committee has called on the Union government to implement immediate restrictions on foreign direct investment (FDI) in private hospitals. The panel warns that an unchecked influx of foreign capital is driving up healthcare costs, effectively pricing millions of Indians out of essential medical services.

The committee's report specifically targets global private equity firms, which have reportedly invested approximately $10 billion into Indian hospital chains over the last five years. Lawmakers expressed concern that this significant financial expansion is transforming vital medical treatment into a high-return profit venture, shifting community healthcare towards a purely capitalistic model.

Foreign Funds Acquiring Existing Hospitals

Instead of investing in building new, much-needed facilities in rural or underserved areas, global funds have predominantly focused on acquiring existing, affordable mid-sized private hospitals. These acquired units are then consolidated into larger corporate networks, creating centralized, high-margin chains.

The committee stated in its report, “The growing presence of foreign capital in private hospital chains is facilitating the acquisition of cost-effective, mid-sized hospitals by larger corporate entities.” This acquisition strategy disproportionately affects middle- and low-income families.

Impact on Healthcare Costs

Once independent local hospitals are absorbed into private equity portfolios, the cost of services such as room charges, diagnostic tests, and surgical procedures escalates rapidly. This increase is driven by the necessity to deliver the double-digit returns expected by international investors.

Policy Overhaul and Price Caps Recommended

To combat annual medical inflation that can reach as high as 13%, the parliamentary committee has recommended that foreign and private capital should supplement, not replace, government health spending. Key recommendations submitted to the Union government include:

• Restricting FDI in Brownfield Assets: Overhauling FDI norms to encourage global funds to build new facilities rather than acquire established, low-cost hospitals.
• Capping Hospital Tariffs: Implementing legal price ceilings on hospital room tariffs, surgical procedures, and diagnostic testing.
• Creating an Independent Sector Regulator: Establishing an official watchdog to penalize excessive markups on medicines and mandate that hospitals publish clear, itemized price lists before patient admission.
• Reserving Subsidised Beds: Requiring corporate hospital chains to allocate a fixed percentage of beds at regulated rates for economically weaker sections.

Resistance to Price Regulations

While private equity-backed hospital chains control less than 5% of India's total hospital beds, they dominate high-margin tertiary specialties like cardiology, oncology, and robotic surgery. Official data indicates that treatments in these facilities can cost five to ten times more than in public hospitals.

Global investment funds, including prominent names like Blackstone, KKR, TPG, General Atlantic, and EQT Group, have reportedly expressed resistance to strict government price controls. They argue that such measures could hinder India's broader economic deregulation and deter future capital commitments for modernizing medical infrastructure.

However, committee members maintain that without firm limits on foreign buyouts and mandatory tariff controls, India's significant "missing middle" population—those who do not qualify for government welfare schemes like Ayushman Bharat but cannot afford corporate hospital rates—will be effectively excluded from essential healthcare services.